• 1
    Banchereau J & Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392: 24552.
  • 2
    Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med 1973;137: 114262.
  • 3
    Sunshine GH, Katz DR, Feldmann M. Dendritic cells induce T cell proliferation to synthetic antigens under Ir gene control. J Exp Med 1980;152: 181722.
  • 4
    Thomas R, Davis LS, Lipsky PE. Isolation and characterization of human peripheral blood dendritic cells. J Immunol 1993;150: 82134.
  • 5
    Sallusto F & Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994;179: 110918.
  • 6
    Shortman K, Caux C. Dendritic cell development: multiple pathways to nature's adjuvants. Stem Cells 1997;15: 40919.
  • 7
    Smith RM, Morgan A, Wraith DC. Anti-class II MHC antibodies prevent and treat EAE without APC depletion. Immunology 1994;83: 18.
  • 8
    Pearson TC, Alexander DZ, Hendrix R et al. CTLA4-Ig plus bone marrow induces long-term allograft survival and donor specific unresponsiveness in the murine model. Evidence for hematopoietic chimerism. Transplantation 1996;61: 9971004.
  • 9
    Webb LMC, Walmsley MJ, Feldmann M. Prevention and amelioration of collagen-induced arthritis by blockade of the CD28 co-stimulatory pathway: requirement for both B7-1 and B7-2. Eur J Immunol 1996;26: 23208.
  • 10
    Miller SD, Vanderlugt CL, Lenschow DJ et al. Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity 1995;3: 73945.
  • 11
    Foxwell B, Browne K, Bondeson J et al. Efficient adenoviral infection with IκBα reveals that macrophage tumor necrosis factor α production in rheumatoid arthritis is NF-κB dependent. Proc Natl Acad Sci USA 1998;95: 82115.
  • 12
    Yoshimura S, Bondeson J, Foxwell BMJ, Brennan FM, Feldmann M. Effective antigen presentation by dendritic cells is NFkappaB dependent: co-ordinate regulation of MHC, costimulatory molecules and cytokines. Int Immunol 2001;13: 67583.
  • 13
    Bondeson J, Browne KA, Brennan FM, Foxwell BMJ, Feldmann M. Selective regulation of cytokine induction by adenoviral gene transfer of IκBα into human macrophages: lipopolysaccharide-induced, but not zymosan-induced, proinflammatory cytokines are inhibited, but IL-10 is nuclear factor-κB independent. J Immunol 1999;162: 293945.
  • 14
    Inaba K, Steinman RM, Witmer Pack M et al. Identification of proliferating dendritic cell precursors in blood. J Exp Med 1992;175: 115767.
  • 15
    Wrighton CJ, Hofer-Warbinek R, Moll T, Eytner R, Bach FH, De Martin R. Inhibition of endothelial cell activation by adenovirus-mediated expression of I kappa B alpha, an inhibitor of the transcription factor NF-kappa B. J Exp Med 1996;183: 101322.
  • 16
    Graham FL & Prevec L. Methods for construction of adenovirus vectors. Mol Biotechnol 1995;3: 20720.
  • 17
    Bondeson J, Foxwell B, Brennan F, Feldmann M. Defining therapeutic targets by using adenovirus: blocking NF-kappaB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators. Proc Natl Acad Sci USA 1999;96: 566873.
  • 18
    Clarke CJP, Taylor-Fishwick DA, Hales A et al. Interleukin-4 inhibits κ light chain expression and NFκB activation but not IκBα degradation in 70Z/3 murine pre-B cells. Eur J Immunol 1995;25: 29616.
  • 19
    Whiteside ST, Visvanathan KV, Goodbourn S. Identification of novel factors that bind to the PRD I region of the human beta-interferon promoter. Nucleic Acids Res 1992;20: 15318.
  • 20
    Sallusto F & Lanzavecchia A. Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression. Immunol Rev 2000;177: 13440.
  • 21
    Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991;9: 27196.
  • 22
    Pettit AR, Quinn C, MacDonald KP et al. Nuclear localization of RelB is associated with effective antigen-presenting cell function. J Immunol 1997;159: 368191.
  • 23
    Carrasco D, Ryseck RP, Bravo R. Expression of relB transcripts during lymphoid organ development: specific expression in dendritic antigen-presenting cells. Development 1993;118: 122131.
  • 24
    Lee JL, Ganster RW, Geller DA, Burckart GJ, Thomson AW, Lu L. Cyclosporine A inhibits the expression of costimulatory molecules on in vitro-generated dendritic cells: association with reduced nuclear translocation of nuclear factor kappa B. Transplantation 1999;68: 125563.
  • 25
    Yoshimura S, Bondeson J, Brennan FM, Foxwell BMJ, Feldmann M. Role of NFkappaB in antigen presentation and in development of regulatory T cells elucidated by treatment of dendritic cells with the proteasome inhibitor PSI. Eur J Immunol 2001;31: 188393.
  • 26
    Calder VL, Bondeson J, Brennan FM, Foxwell BMJ, Feldmann M. Antigen-specific T-cell downregulation by human dendritic cells following blockade of NF-Kappa B. Scand J Immunol 2003;57: 26170.
  • 27
    Ammon C, Mondal K, Andreesen R, Krause SW. Differential expression of the transcription factor NF-kappaB during human mononuclear phagocyte differentiation to macrophages and dendritic cells. Biochem Biophys Res Commun 2000;268: 99105.
  • 28
    Morelli AE, Larregina AT, Ganster RW et al. Recombinant adenovirus induces maturation of dendritic cells via a NF-kappaB- dependent pathway. J Virol 2000;74: 961728.
  • 29
    Thomas JM, Contreras JL, Jiang XL et al. Peritransplant tolerance induction in macaques: early events reflecting the unique synergy between immunotoxin and deoxyspergualin. Transplantation 1999;68: 166073.
  • 30
    Giannoukakis N, Bonham CA, Qian S et al. Prolongation of cardiac allograft survival using dendritic cells treated with NF-kappaB decoy oligodeoxyribonucleotides. Mol Ther 2000;1: 4307.